MindMed reports First Quarter 2020 Results
TORONTO, May 14, 2020: Mind Medicine (MindMed) Inc. (“MindMed” or the “Company”) (NEO: MMED, OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, today announced the release of its unaudited condensed consolidated financial statements (the “Financial Statements”) and accompanying management’s discussion and analysis (the “MD&A”) for the quarter ended March 31, 2020. All financial […]
Falcon Extends Warrants & Appoints CFO
Vancouver, B.C., May 14th, 2020. FALCON GOLD CORP. (FG:TSX-V), (3FA:GR); (“Falcon” or “the Company“) announces that it has applied to the TSX Venture Exchange to extend the term of 4,420,000 common share purchase warrants originally set to expire (“The Warrants”) on May 18,2020. The warrants were originally issued pursuant to a private placement dated April […]